Assessing the impact of discontinuation of formulary prior authorization on antibiotic prescribing
Teagan Zeggil, Tony Nickonchuk, Elissa Rennert-May, Irina Rajakumar

TL;DR
This study examines how removing prior authorization for antibiotics affects prescribing patterns and evaluates a program to reduce inappropriate use.
Contribution
The study introduces a prospective audit and feedback program to address potential inappropriate antibiotic prescribing after policy changes.
Findings
Removal of prior authorization led to a non-significant trend toward increased antibiotic use.
The audit and feedback program identified 9.8% of patients needing intervention, with 69.2% of suggestions accepted.
Most interventions involved narrowing the antibiotic spectrum, but overall changes in antibiotic use were not statistically significant.
Abstract
To compare prescribing patterns of restricted antimicrobials before and after the removal of prior authorization and to develop a prospective audit and feedback program to mitigate the potential inappropriate prescribing of these antimicrobials. An interrupted time-series analysis assessing the trends in antibiotic use was conducted between May 2020 and February 2023 in large urban hospitals, where all ASP activities were discontinued in May 2022 and a pilot prospective audit and feedback (PAF) program was initiated in January 2023. The collective change in restricted antibiotic utilization after the removal of prior authorization was trending towards increased utilization but was not statistically significant. With the PAF program, 9.8% of patients were identified by the antimicrobial stewardship pharmacists as requiring intervention. Within these patients, 19 different…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAntibiotic Use and Resistance · Pharmaceutical Practices and Patient Outcomes · Pharmacovigilance and Adverse Drug Reactions
